Clinical Trial Update: Endothelial Effects of Basal Insulin: Detemir Versus Glargine [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the endothelial effects of basal insulins detemir and glargine in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Levemir (insulin detemir)

Snippet

Sponsor: University of Padova | Conditions: Type 2 Diabetes, Endothelial Dysfunction | Phase 4 | Status: COMPLETED